Why Australian Pharmaceutical Industries Ltd (ASX:API) shares are up 8% today

Australian Pharmaceutical Industries Ltd (ASX:API) shares are up after the company announced an acquisition.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Shares in Australian Pharmaceutical Industries Ltd (ASX: API), the health and beauty company which is partly owned by Washington H. Soul Pattinson and Co. Ltd (ASX: SOL), were up 8% today after the company announced a $127.4 million agreement to acquire the assets of Clearskincare Clinics.

The purchase price will be paid in installments over three years.

According to the announcement, API will initially acquire a 50.1% controlling stake and gradually increase this to 100% ownership by September 2021.

The transaction will be funded by debt facilities that have been established for the acquisition.

Clearskincare has 42 clinics in Australia and 2 in New Zealand which provide laser hair removal, skin treatments and cosmetic injectable services.

Impact on API's earnings

API said that after accounting for interest costs on new debt facilities, it expects the impact of the acquisition to be earnings per share (EPS) positive in FY 19. This is based on Clearskincare clinics' track record of growth and strong cash generation which is expected to continue going forward.

Benefits to API

In addition to being EPS accretive, management flagged a number of benefits for API in doing this deal including:

  • Marketing synergies given that Clearskincare and Priceline have a similar customer base
  • Diversification of revenue sources away from government funding
  • Well managed founder led business with an established market position

Foolish Takeaway

The full $127.4 million acquisition was made based on a valuation of 7.6 times EBITDA and the initial payment was based on a valuation 8.9 times FY 19's forecast EBITDA.

This is a premium to the 6 times EBITDA that API itself trades at (assuming the second half of  FY 18 replicates the 1H18 EBITDA of $58.7 million).

That's not cheap for a slow growing business but API has defensive qualities and strong consumer brands such as Priceline and Soul Pattinson. The Clearskincare acquisition will complement and diversify this suite of brands.

API has a 10-year dividend growth rate of 26% and looking forward, I expect that to continue as the company benefits from a growing and ageing population.

Motley Fool contributor Kevin Gandiya has no position in any of the stocks mentioned. You can find Kevin on Twitter @KevinGandiya. The Motley Fool Australia owns shares of and has recommended Washington H. Soul Pattinson and Company Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »